arginine has been researched along with Epistaxis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bari, N; Ho, JPK; Riffat, F | 1 |
| Azanza, JR; Campanero, MA; Esteras, A; García-Quetglas, E; Gil-Aldea, I; Muñoz-Juarez, MJ; Sádaba, B | 1 |
1 trial(s) available for arginine and Epistaxis
| Article | Year |
|---|---|
A comparative study of the pharmacokinetics of ibuprofen arginate versus dexibuprofen in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Algorithms; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Arginine; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Epistaxis; Female; Half-Life; Headache; Humans; Ibuprofen; Male; Metabolic Clearance Rate; Stereoisomerism; Therapeutic Equivalency; Time Factors | 2006 |
1 other study(ies) available for arginine and Epistaxis
| Article | Year |
|---|---|
Management of epistaxis in patients on novel oral anticoagulation therapy.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Antithrombins; Arginine; Awareness; Dabigatran; Epistaxis; Factor Xa; Factor Xa Inhibitors; First Aid; Humans; Male; Piperazines; Prevalence; Recombinant Proteins; Rivaroxaban; Severity of Illness Index | 2020 |